BioTime (BTX +4.8%) trades up after signing an agreement with USCN Life Science of Wuhan, China,...

|By:, SA News Editor

BioTime (BTX +4.8%) trades up after signing an agreement with USCN Life Science of Wuhan, China, to license its antibody-producing cell lines and related technology for use in the large-scale manufacture of antibody components for its cancer detection device, PanC-Dx.